How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Opthalmic Electric Operation Table Market
- By Operation Table Type: Hydraulic Operation Table, Electric Operation Table, Manual Operation Table, Hybrid Operation Table
- By Table Configuration: Single-Section Table, Two-Section Table, Three-Section Table, Four-Section Table
- By Patient Positioning Capability: Trendelenburg Position, Reverse Trendelenburg Position, Lateral Tilt, Height Adjustment, Backrest Adjustment
- By Control Mechanism: Wired Remote Control, Wireless Remote Control, Foot Control, Touchscreen Control Panel
- By Material and Finish: Stainless Steel Frame, Aluminum Alloy Frame, Antimicrobial Coating, Radiolucent Tabletop
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Hydraulic Operation Table leads By Operation Table Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Opthalmic Electric Operation Table Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Operation Table Type 4
Table Configuration 4
Patient Positioning Capability 5
Control Mechanism 4
Material and Finish 4
Companies profiled
Maquet (Getinge Group)
Stryker Corporation
Steris plc
Skytron LLC
Mizuho OSI
Berchtold Holding GmbH & Co. KG
A-dec Inc.
Trumpf Medical
Hill-Rom Holdings Inc.
DRE Medical Inc.
Arthrex Inc.
Sterisafe
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Maquet (Getinge Group)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Steris plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Skytron LLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Mizuho OSI
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Berchtold Holding GmbH & Co. KG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →A-dec Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Trumpf Medical
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Hill-Rom Holdings Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →DRE Medical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Arthrex Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Sterisafe
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →B. Braun Melsungen AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Mediland Enterprise Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Shandong Yuwell Medical Equipment Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,615M by 2033 · 5.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Hydraulic Operation Table52.6
- Electric Operation Table19.4
- Manual Operation Table9.8
- Hybrid Operation Table18.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,649M → $2,340M · 4.5%
Europe$1,149M → $1,933M · 6.7%
Asia Pacific$1,049M → $1,781M · 6.8%
Latin America$649.5M → $983.7M · 5.3%
Middle East and Africa$499.6M → $752.1M · 5.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.362026
5.382027
5.382028
5.402029
5.412030
5.412031
5.442032
5.452033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Maquet (Getinge Group)25.4
- Stryker Corporation11.1
- Steris plc4.9
- Skytron LLC9.1
- Mizuho OSI13.7
- Berchtold Holding GmbH & Co. KG7.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Operation Table Type26.4%
Table Configuration11.5%
Patient Positioning Capability26.0%
Control Mechanism12.2%
Material and Finish23.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.0
- Europe24.8
- Asia Pacific22.9
- Latin America12.6
- Middle East and Africa9.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Maquet (Getinge Group) | 75 | 96 | 86 | 91 | 93 | 90 | 89 |
| Stryker Corporation | 92 | 87 | 77 | 70 | 83 | 73 | 80 |
| Steris plc | 81 | 71 | 67 | 85 | 67 | 71 | 74 |
| Skytron LLC | 73 | 61 | 59 | 59 | 76 | 60 | 65 |
| Mizuho OSI | 63 | 53 | 74 | 69 | 64 | 62 | 64 |
| Berchtold Holding GmbH & Co. KG | 50 | 65 | 70 | 50 | 65 | 60 | 60 |
| A-dec Inc. | 51 | 45 | 66 | 45 | 62 | 62 | 55 |
| Trumpf Medical | 58 | 46 | 47 | 46 | 50 | 40 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Maquet (Getinge Group)
- Stryker Corporation
- Steris plc
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Maquet (Getinge Group) | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Stryker Corporation | ◐ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Steris plc | ✓ | ✓ | ◐ | ✓ | ◐ | − |
| Skytron LLC | ✓ | ◐ | ◐ | − | ✓ | ◐ |
| Mizuho OSI | ✓ | − | ✓ | ◐ | ◐ | ◐ |
| Berchtold Holding GmbH & Co. KG | ◐ | ◐ | ◐ | − | ◐ | ◐ |
| A-dec Inc. | − | − | ◐ | − | − | ◐ |
| Trumpf Medical | − | ◐ | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Maquet (Getinge Group)89
2Stryker Corporation80
3Steris plc74
4Skytron LLC65
5Mizuho OSI64
6Berchtold Holding GmbH & Co. KG60
7A-dec Inc.55
8Trumpf Medical48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Maquet (Getinge Group)Stryker Corporation
Challenger1
Strong scale, closing on the leaders.
Steris plc
Contender3
Focused players with pockets of strength.
Skytron LLCMizuho OSIBerchtold Holding GmbH & Co. KG
Niche2
Specialists in a single segment or region.
A-dec Inc.Trumpf Medical
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Operation Table Type in North America, then scale across Opthalmic Electric Operation Table Market — a $267M beachhead inside a $4.70B market.
Beachhead (SOM)$267Mobtainable near-term
Serviceable (SAM)$1.74Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Hydraulic Operation Table
Best fit — highest urgency & budget in Operation Table Type.
Economic buyer77 fit
Electric Operation Table
Strong fit — clear ROI and a fast path to value.
End user65 fit
Manual Operation Table
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Operation Table Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Table Configuration & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Patient Positioning Capability
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel29%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Operation Table Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Opthalmic Electric Operation Table Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified23%
Evaluation15%
Closed-won6%
$9.0KCAC
$38KLTV
4.3:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Opthalmic Electric Operation Table Market is a durable-growth opportunity — $11.6B by 2033, compounding at 9.9%.
TAM · 2025$5.45Btoday
TAM · 2033$11.6Bforecast
CAGR9.9%2027–2033
Cumulative$73.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$11.6BTotal addressable market
SAM$4.43BServiceable available market
SOM$815MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.9% CAGR
Demand compounds through 2033, outpacing GDP across Operation Table Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Operation Table Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$11.6BLarge & growingTAM by 2033 at 9.9% CAGR
$4.43BServiceable nowreachable with today’s model
$815MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$9.05BBear6.4% CAGR
$11.6BBase9.9% CAGR
$14.8BBull13.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Table Configuration optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Opthalmic Electric Operation Table Market — a $9.39B market by 2033. Plan: grow share from 9.5% to 18.5%.
Market size · 2033$9.39Btotal addressable
Market CAGR7.5%2027–2033
Target share18.5%from 9.5% today
Revenue ambition$1.74Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.5% | 18.5% | On track |
| Revenue | $865M | $1.74B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 36.6% | 45.3% | On track |
| Customer retention | 84.9% | 93.0% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Operation Table Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Table Configuration capability
A defensible second engine — invest in Table Configuration to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Operation Table Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Table Configuration
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $225M capacity & capability investment
- Greenlight bolt-on M&A in Table Configuration
- Authorise North America expansion plan
- Fund R&D program for Operation Table Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Opthalmic Electric Operation Table Market conversation — a $6.14B market you can size, segment and defend in minutes.
Market size · 2033$6.14Btotal opportunity
Growth6.5%CAGR to 2033
Addressable buyers1,156+accounts in scope
Typical ROI7.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Operation Table Type
Goal Grow share in Operation Table Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.5×return on cost, year one
< 3 mopayback period
$44K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Maquet (Getinge Group)Stryker CorporationSteris plcSkytron LLCMizuho OSIBerchtold Holding GmbH & Co. KGA-dec Inc.Trumpf Medical+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Opthalmic Electric Operation Table Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Opthalmic Electric Operation Table Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Opium Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportOpipramol Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportOpioid Withdrawal Management Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportOpioid Receptor Agonist Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportOpioid Pain Patche Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportOpioid Induced Side Effects Treatment Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportOpioid Induced Constipation (OlC) Drugs Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportOpioid Induced Constipation (OIC) Drugs Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportOpioid Dependence Treatment Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportOpioid Antagonist Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportOpioid Analgesics Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportOpiate Antagonist Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.